Correction of oral contrast artifacts in CT-based attenuation correction of PET images using an automated segmentation algorithm

Purpose  Oral contrast is usually administered in most X-ray computed tomography (CT) examinations of the abdomen and the pelvis as it allows more accurate identification of the bowel and facilitates the interpretation of abdominal and pelvic CT studies. However, the misclassification of contrast medium with high-density bone in CT-based attenuation correction (CTAC) is known to generate artifacts in the attenuation map (μmap), thus resulting in overcorrection for attenuation of positron emission tomography (PET) images. In this study, we developed an automated algorithm for segmentation and classification of regions containing oral contrast medium to correct for artifacts in CT-attenuation-corrected PET images using the segmented contrast correction (SCC) algorithm. Methods  The proposed algorithm consists of two steps: first, high CT number object segmentation using combined region- and boundary-based segmentation and second, object classification to bone and contrast agent using a knowledge-based nonlinear fuzzy classifier. Thereafter, the CT numbers of pixels belonging to the region classified as contrast medium are substituted with their equivalent effective bone CT numbers using the SCC algorithm. The generated CT images are then down-sampled followed by Gaussian smoothing to match the resolution of PET images. A piecewise calibration curve was then used to convert CT pixel values to linear attenuation coefficients at 511 keV. Results  The visual assessment of segmented regions performed by an experienced radiologist confirmed the accuracy of the segmentation and classification algorithms for delineation of contrast-enhanced regions in clinical CT images. The quantitative analysis of generated μmaps of 21 clinical CT colonoscopy datasets showed an overestimation ranging between 24.4% and 37.3% in the 3D-classified regions depending on their volume and the concentration of contrast medium. Two PET/CT studies known to be problematic demonstrated the applicability of the technique in clinical setting. More importantly, correction of oral contrast artifacts improved the readability and interpretation of the PET scan and showed substantial decrease of the SUV (104.3%) after correction. Conclusions  An automated segmentation algorithm for classification of irregular shapes of regions containing contrast medium was developed for wider applicability of the SCC algorithm for correction of oral contrast artifacts during the CTAC procedure. The algorithm is being refined and further validated in clinical setting.     

Comparison of activity expression between PET using 68Ge-68Ga line source attenuation correction and PET-CT using CT attenuation correction: impact on emission images

OBJECTIVES: CT data can be used for both anatomical image and attenuation correction (CTAC) of PET data in PET-CT scanners. The CTAC method is useful for attenuation correction, because the CT scan time is much shorter than the external radionuclide (e.g., (68)Ge) transmission scan time. However, the energy of the X-rays from CT is not monoenergetic and is much lower than that of the external radionuclide source. In this study, we evaluated the differences between emission PET images reconstructed with CT-based and (68)Ge-based attenuation correction. METHODS: CT scans and (68)Ge-Transmission scans were acquired and used for attenuation correction (CTAC, MAC, and SAC). The PET emission scan time was 4 min. CT scans were acquired at 10, 20, 40, 80, and 160 mA. (68)Ge-Transmission scans were acquired at 1, 3, 5, 10, 20, 40, 60, and 300 min. The attenuation-corrected emission image using MAC on a 300 min transmission scan was defined as the reference image. Seven cylinders (30 mm diameter) were filled with (18)F-FDG placed in a heart-liver phantom with simulated pulmonary mass lesions. The PET value [counts/cc] was measured in circular regions of interest (ROI) over the cylindrical mass lesion. Averages [counts/cc], coefficients of variation [C.V.(%)], and ratios of difference [%Diff] from the reference value were calculated for all conditions. RESULTS: In the CT-Transmission, analysis of variance revealed no significant effect of CT current on the average and the C.V. In the (68)Ge-Transmission, the average and the C.V. changed in dependence on the acquisition time. All %Diff using CT-Transmission were small. It was shown that CT-Transmission is more appropriate than (68)Ge-Transmission.     

Respiratory motion artifacts on PET emission images obtained using CT attenuation correction on PET-CT

PET-CT scanners allow generation of transmission maps from CT. The use of CT attenuation correction (CTAC) instead of germanium-68 attenuation correction (Ge AC) might be expected to cause artifacts on reconstructed emission images if differences in respiratory status exist between the two methods of attenuation correction. The aim of this study was to evaluate for possible respiratory motion artifacts (RMA) in PET images attenuation corrected with CT from PET-CT in clinical patients. PET-CT scans were performed using a Discovery LS PET-CT system in 50 consecutive patients (23 males, 27 females; mean age 58.2 years) with known or suspected malignancy. Both CTAC and Ge AC transmission data obtained during free tidal breathing were used to correct PET emission images. Cold artifacts at the interface of the lungs and diaphragm, believed to be due to respiratory motion (RMA), that were seen on CTAC images but not on the Ge AC images were evaluated qualitatively on a four-point scale (0, no artifact; 1, mild artifact; 2, moderate artifact; 3, severe artifact). RMA was also measured for height. Curvilinear cold artifacts paralleling the dome of the diaphragm at the lung/diaphragm interface were noted on 84% of PET-CT image acquisitions and were not seen on the (68)Ge-corrected images; however, these artifacts were infrequently severe. In conclusion, RMA of varying magnitude were noted in most of our patients as a curvilinear cold area at the lung/diaphragm interface, but were not diagnostically problematic in these patients.     

Optimized intravenous contrast administration for diagnostic whole-body 18F-FDG PET/CT.

Standard application of CT intravenous contrast agents in combined PET/CT may lead to high-density artifacts on CT and attenuation-corrected PET. To avoid associated diagnostic pitfalls, we designed and compared different intravenous contrast injection protocols for routine whole-body PET/CT. METHODS: Whole-body PET/CT included a topogram and a single spiral CT scan (2-row) with or without intravenous contrast, followed by an emission scan. The CT scan was used for attenuation correction of the emission data. Four groups of 10 whole-body PET/CT referrals each were investigated: (A) no intravenous contrast agent, (B) biphasic injection (90 and 50 mL at 3 and 1.5 mL/s, respectively) of intravenous contrast (300 mg/mL iodine) and CT in the craniocaudal direction with a 30-s delay, (C) triple-phase injection (90, 40, and 40 mL at 3, 2, and 1.5 mL/s, respectively) in the craniocaudal direction with a 50-s delay, and (D) dual-phase injection (80 and 60 mL at 3 and 1.5 mL/s, respectively) in the caudocranial direction with a 50-s delay. CT image quality was assessed on a scale from 1 to 3, and CT and attenuation-corrected PET images were reviewed separately for contrast-induced artifacts. RESULTS: Average CT image quality was poorest for protocol A (1.0) but improved to 2.8 when using intravenous contrast agents (protocols B-D). Only protocols B and C resulted in contrast-induced image artifacts that were limited to the thorax. The most homogeneous intravenous contrast enhancement without high-density image artifacts on either CT or PET after CT-based attenuation correction was achieved with protocol D. CONCLUSION: Dual-phase intravenous contrast injection and CT in the caudocranial direction with a 50-s delay yields reproducible high image quality and is now used routinely for combined diagnostic PET/CT at our hospital.     

不同浓度泛影葡胺及不同CT扫描条件对PET/CT图像质量和标准摄取值的影响

目的 探讨不同浓度泛影葡胺及不同CT扫描条件对PET/CT图像质量和标准摄取值的影响.材料与方法 分别将2％、5％、10％、15％、30％的泛影葡胺溶液置入一圆桶模型中进行PET/CT显像,同时采用CT及37Cs两种衰减方法进行校正.比较不同管电压(90kV、120kV、140kV) CT扫描条件下各浓度泛影葡胺充盈区CT衰减校正(CTAC)和137Cs衰减校正(CsAC)的标准摄取值差异及图像差异.结果 不同管电压CT扫描条件下的CT衰减校正的标准摄取值均随泛影葡胺浓度增加而增加(r=0.977、0.979、0.985,P＜0.01),而137Cs衰减校正的标准摄取值则与泛影葡胺浓度无明显相关性(r=0.386,P＞ 0.05);在本底区、清水充盈区及浓度为2％的泛影葡胺充盈区,各CT衰减校正和137Cs衰减校正的标准摄取值间差异无统计学意义(F=1.222、0.912、0.721,P＞0.05);在浓度为5％、10％、15％、30％的泛影葡胺充盈区,CT衰减校正的标准摄取值明显高于137Cs衰减校正值(F=82.571、348.211、569.630、992.746,P＜0.01),管电压越高CT衰减校正的标准摄取值越小.在浓度为15％、30％的泛影葡胺充盈区,不同管电压CT扫描条件下的图像均出现18F-FDG高摄取伪影,以140kV下的图像“热区”范围及强度最小,而相同区域的137Cs衰减校正及无衰减校正图像均表现为圆形“冷区”.结论 高浓度(≥5％)的泛影葡胺可使PET图像出现高摄取伪影或标准摄取值的高估,增加CT扫描管电压值可以减轻图像伪影并减小标准摄取值的误差.     

PET/CT imaging artifacts

The purpose of this paper is to introduce the principles of PET/CT imaging and describe the artifacts associated with it. PET/CT is a new imaging modality that integrates functional (PET) and structural (CT) information into a single scanning session, allowing excellent fusion of the PET and CT images and thus improving lesion localization and interpretation accuracy. Moreover, the CT data can also be used for attenuation correction, ultimately leading to high patient throughput. These combined advantages have rendered PET/CT a preferred imaging modality over dedicated PET. Although PET/CT imaging offers many advantages, this dual-modality imaging also poses some challenges. CT-based attenuation correction can induce artifacts and quantitative errors that can affect the PET emission images. For instance, the use of contrast medium and the presence of metallic implants can be associated with focal radiotracer uptake. Furthermore, the patient's breathing can introduce mismatches between the CT attenuation map and the PET emission data, and the discrepancy between the CT and PET fields of view can lead to truncation artifacts. After reading this article, the technologist should be able to describe the principles of PET/CT imaging, identify at least 3 types of image artifacts, and describe the differences between PET/CT artifacts of different causes: metallic implants, respiratory motion, contrast medium, and truncation.     

Cine CT for attenuation correction in cardiac PET/CT.

In dual-modality PET/CT systems, the CT scan provides the attenuation map for PET attenuation correction. The current clinical practice of obtaining a single helical CT scan provides only a snapshot of the respiratory cycle, whereas PET occurs over multiple respiratory cycles. Misalignment of the attenuation map and emission image because of respiratory motion causes errors in the attenuation correction factors and artifacts in the attenuation-corrected PET image. To rectify this problem, we evaluated the use of cine CT, which acquires multiple low-dose CT images during a respiratory cycle. We evaluated the average and the intensity-maximum image of cine CT for cardiac PET attenuation correction. METHODS: Cine CT data and cardiac PET data were acquired from a cardiac phantom and from multiple patient studies. The conventional helical CT, cine CT, and PET data of an axially translating phantom were evaluated with and without respiratory motion. For the patient studies, we acquired 2 cine CT studies for each PET acquisition in a rest-stress (13)N-ammonia protocol. Three readers visually evaluated the alignment of 74 attenuation image sets versus the corresponding emission image and determined whether the alignment provided acceptable or unacceptable attenuation-corrected PET images. RESULTS: In the phantom study, the attenuation correction from helical CT caused a major artifactual defect in the lateral wall on the PET image. The attenuation correction from the average and from the intensity-maximum cine CT images reduced the defect by 20% and 60%, respectively. In the patient studies, 77% of the cases using the average of the cine CT images had acceptable alignment and 88% of the cases using the intensity maximum of the cine CT images had acceptable alignment. CONCLUSION: Cine CT offers an alternative to helical CT for compensating for respiratory motion in the attenuation correction of cardiac PET studies. Phantom studies suggest that the average and the intensity maximum of the cine CT images can reduce potential respiration-induced misalignment errors in attenuation correction. Patient studies reveal that cine CT provides acceptable alignment in most cases and suggest that the intensity-maximum cine image offers a more robust alternative to the average cine image.     

Feasibility of diagnostic contrast-enhanced CT for attenuation correction of whole body PET images

OBJECTIVE: Image fusion has been recognized as a useful technique in diagnostic imaging. We have been evaluating the manual image fusion of PET and contrast-enhanced (CE) CT obtained separately. The CT images can be used for attenuation correction as well as for image fusion; however, the quantitative accuracy of CT-corrected PET images has yet to be assessed. The purpose of this study was to compare the radioactivity concentration between conventional (68)Ge-corrected and CECT-corrected PET images. METHODS: Twenty patients underwent a whole-body PET scan, followed by a CT scan with intravenous contrast material, after careful positioning using an individually molded vacuum cushion. Two different attenuation-corrected emission data sets were produced, i.e., (68)Ge-corrected images and CECT-corrected images. Image registration was performed by maximizing mutual information-based cost function, between the CT and the combination of emission and transmission PET volumes. The CT pixel values in Hounsfield units were transformed into linear attenuation coefficients in cm(-1), using a conversion formula for a lookup-table from phantom experiments. Measured activity concentrations from identical regions of interest in representative normal organs and in 25 pathologic foci of uptake were compared. In addition, the quality of the reconstructed images was assessed using the normal mean square error (NMSE). RESULTS: Measured average radioactivity concentrations were 1.38-9.56% higher for CECT-corrected images than for (68)Ge-corrected images. Overall, the NMSE value of CECT-corrected images compared with (68)Ge-corrected images was 0.02+/-0.01. CONCLUSIONS: The difference in quantitative values between (68)Ge-corrected and CECT-corrected PET images was comparable to that of an integrated PET/CT system. Diagnostic CT images with intravenous contrast performed separately before or after a PET scan could be used clinically not only for fusion but also for attenuation correction.     

PET/CT: comparison of quantitative tracer uptake between germanium and CT transmission attenuation-corrected images.

In PET, transmission scanning for attenuation correction has most commonly been performed with an external positron-emitting radionuclide source, such as (68)Ge. More recently, combined PET/CT scanners have been developed in which the CT data can be used for both anatometabolic image formation and attenuation correction of the PET data. The purpose of this study was to assess the quantitative differences between CT-based and germanium-based attenuation-corrected PET images. METHODS: Twenty-eight patients with known or suspected cancer underwent whole-body (18)F-FDG PET/CT scanning for clinical diagnostic purposes. For each patient, attenuation maps were obtained from both the CT scan and the (68)Ge transmission data, and 2 different attenuation-corrected emission datasets were produced. Measured activity concentrations (both mean and maximum) from identical regions of interest in representative normal organs and in 36 pathologic foci of uptake were compared. RESULTS: CT-corrected emission images generally showed slightly higher radioactive concentration values than did germanium-corrected images (P < 0.01) for all lesions and all normal organs except the lung. Mean and maximum radioactivity concentrations were 4.3%-15.2% higher for CT-corrected images than for germanium-corrected images. Calculated radioactivity concentrations were significantly greater in osseous lesions than in nonosseous lesions (11.0% vs. 2.3%, P < 0.05, for mean value; 11.1% vs. 2.1%, P < 0.01, for maximum value). A weak positive correlation was observed between the CT Hounsfield units within the regions of interest and the percentage difference in apparent tracer activity in the CT-corrected images. CONCLUSION: Although quantitative radioactivity values are generally comparable between CT- and germanium-corrected emission PET images, CT-based attenuation correction produced radioactivity concentration values significantly higher than the germanium-based corrected values. These effects, especially in radiodense tissues, should be noted when using and comparing quantitative PET analyses from PET and PET/CT systems.     

Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma.

The purpose of this study was to compare (18)F-FDG PET and PET/CT in a population of patients with colorectal cancer. METHODS: PET and PET/CT images from 45 patients (17 women, 28 men; mean age +/- SD, 60.8 +/- 11.1 y) with known colorectal cancer referred for PET from June to November 2001 were retrospectively reviewed. Images were acquired with a PET/CT scanner, and (68)Ge attenuation correction was applied. PET images and fused (68)Ge attenuation-corrected PET and CT images were independently and separately interpreted by a moderately experienced reader unaware of the clinical information. Certainty of lesion characterization was scored on a 5-point scale (0 = definitely benign, 1 = probably benign, 2 = equivocal, 3 = probably malignant, 4 = definitely malignant). Lesion location was scored on a 3-point scale (0 = uncertain, 1 = probable, 2 = definite). The presence or absence of tumor was subsequently assessed using all available clinical, pathologic, and follow-up information. Analysis was provided for lesions detected by both PET and PET/CT. RESULTS: The frequency of equivocal and probable lesion characterization was reduced by 50% (50 to 25) with PET/CT, in comparison with PET. The frequency of definite lesion characterization was increased by 30% (84 to 109) with PET/CT. The number of definite locations was increased by 25% (92 to 115) with PET/CT. Overall correct staging increased from 78% to 89% with PET/CT on a patient-by-patient analysis. CONCLUSION: PET/CT imaging increases the accuracy and certainty of locating lesions in colorectal cancer. More definitely normal and definitely abnormal lesions (and fewer probable and equivocal lesions) were identified with PET/CT than with PET alone. Staging and restaging accuracy improved from 78% to 89%.     

Does reducing CT artifacts from dental implants influence the PET interpretation in PET/CT studies of oral cancer and head and neck cancer?

In patients with oral head and neck cancer, the presence of metallic dental implants produces streak artifacts in the CT images. These artifacts negate the utility of CT for the spatial localization of PET findings and may propagate through the CT-based attenuation correction into the PET images. In this study, we evaluated the efficacy of an algorithm that reduces metallic artifacts in CT images and the impact of this approach on the quantification of PET images. METHODS: Fifty-one patients with and 9 without dental implants underwent a PET/CT study. CT images through the patient's dental implants were reconstructed using both standard CT reconstruction and an algorithm that reduces metallic artifacts. Attenuation correction factors were calculated from both sets of CT images and applied to the PET data. The CT images were evaluated for any reduction of the artifacts. The PET images were assessed for any quantitative change introduced by metallic artifact reduction. RESULTS: For each reconstruction, 2 regions of interest were defined in areas where the standard CT reconstruction overestimated the Hounsfield units (HU), 2 were defined in underestimated areas, and 1 was defined in a region unaffected by the artifacts. The 5 regions of interest were transferred to the other 3 reconstructions. Mean HU or mean Bq/cm(3) were obtained for all regions. In the CT reconstructions, metallic artifact reduction decreased the overestimated HUs by approximately 60% and increased the underestimated HUs by approximately 90%. There was no change in quantification in the PET images between the 2 algorithms (Spearman coefficient of rank correlation, 0.99). Although the distribution of attenuation (HU) changed considerably in the CT images, the distribution of activity did not change in the PET images. CONCLUSION: Our study demonstrated that the algorithm can enhance the structural and spatial content of CT images in the presence of metallic artifacts. The CT artifacts do not propagate through the CT-based attenuation correction into the PET images, confirming the robustness of CT-based attenuation correction in the presence of metallic artifacts. The study also demonstrated that considerable changes in CT images do not change the PET images.     

Head and neck imaging with PET and PET/CT: artefacts from dental metallic implants

Germanium-68 based attenuation correction (PET(Ge68)) is performed in positron emission tomography (PET) imaging for quantitative measurements. With the recent introduction of combined in-line PET/CT scanners, CT data can be used for attenuation correction. Since dental implants can cause artefacts in CT images, CT-based attenuation correction (PET(CT)) may induce artefacts in PET images. The purpose of this study was to evaluate the influence of dental metallic artwork on the quality of PET images by comparing non-corrected images and images attenuation corrected by PET(Ge68) and PET(CT). Imaging was performed on a novel in-line PET/CT system using a 40-mAs scan for PET(CT) in 41 consecutive patients with high suspicion of malignant or inflammatory disease. In 17 patients, additional PET(Ge68) images were acquired in the same imaging session. Visual analysis of fluorine-18 fluorodeoxyglucose (FDG) distribution in several regions of the head and neck was scored on a 4-point scale in comparison with normal grey matter of the brain in the corresponding PET images. In addition, artefacts adjacent to dental metallic artwork were evaluated. A significant difference in image quality scoring was found only for the lips and the tip of the nose, which appeared darker on non-corrected than on corrected PET images. In 33 patients, artefacts were seen on CT, and in 28 of these patients, artefacts were also seen on PET imaging. In eight patients without implants, artefacts were seen neither on CT nor on PET images. Direct comparison of PET(Ge68) and PET(CT) images showed a different appearance of artefacts in 3 of 17 patients. Malignant lesions were equally well visible using both transmission correction methods. Dental implants, non-removable bridgework etc. can cause artefacts in attenuation-corrected images using either a conventional 68Ge transmission source or the CT scan obtained with a combined PET/CT camera. We recommend that the non-attenuation-corrected PET images also be evaluated in patients undergoing PET of the head and neck.     

Effective methods to correct contrast agent-induced errors in PET quantification in cardiac PET/CT.

In combined PET/CT studies, x-ray attenuation information from the CT scan is generally used for PET attenuation correction. Iodine-containing contrast agents may induce artifacts in the CT-generated attenuation map and lead to an erroneous radioactivity distribution on the corrected PET images. This study evaluated 2 methods of thresholding the CT data to correct these contrast agent-related artifacts. METHODS: PET emission and attenuation data (acquired with and without a contrast agent) were simulated using a cardiac torso software phantom and were obtained from patients. Seven patients with known coronary artery disease underwent 2 electrocardiography-gated CT scans of the heart, the first without a contrast agent and the second with intravenous injection of an iodine-containing contrast agent. A 20-min PET scan (single bed position) covering the same axial range as the CT scans was then obtained 1 h after intravenous injection of (18)F-FDG. For both the simulated data and the patient data, the unenhanced and contrast-enhanced attenuation datasets were used for attenuation correction of the PET data. Additionally, 2 threshold methods (one requiring user interaction) aimed at compensating for the effect of the contrast agent were applied to the contrast-enhanced attenuation data before PET attenuation correction. All PET images were compared by quantitative analysis. RESULTS: Regional radioactivity values in the heart were overestimated when the contrast-enhanced data were used for attenuation correction. For patients, the mean decrease in the left ventricular wall was 23%. Use of either of the proposed compensation methods reduced the quantification error to less than 5%. The required time for postprocessing was minimal for the user-independent method. CONCLUSION: The use of contrast-enhanced CT images for attenuation correction in cardiac PET/CT significantly impairs PET quantification of tracer uptake. The proposed CT correction methods markedly reduced these artifacts; additionally, the user-independent method was time-efficient.     

Whole-body 18F-FDG PET/CT in the presence of truncation artifacts.

We investigated the effect of CT truncation in whole-body (WB) PET/CT imaging of large patients, and we evaluated the efficacy of an extended field-of-view (eFOV) correction technique. METHODS: Two uniform phantoms simulating a "torso" and an "arms-up" setup were filled with (18)F-FDG/water. A third, nonuniform "body phantom was prepared with hot and cold lesions. All 3 phantoms were positioned in the center of the PET/CT gantry with >or=10% of their volume extending beyond the maximum CT FOV. An eFOV algorithm was used to estimate complete CT projections from nonlinear extrapolation of the truncated projections. CT-based attenuation correction (CT AC) of the phantom data was performed using CT images reconstructed from truncated and extended projections. For clinical validation, we processed truncated datasets from 10 PET/CT patients with and without eFOV correction. RESULTS: When using truncated CT images for CT AC, PET tracer distribution was suppressed outside the transverse CT FOV in phantom and patient studies. PET activity concentration in the truncated regions was only 10%-32% of the true value but increased to 84%-100% when using the extended CT images for CT AC. At the same time, the contour of phantoms and patients was recovered to the anatomically correct shape from the uncorrected emission images, and the apparent distortion of lesions near the maximum CT FOV was reduced. CONCLUSION: Truncation artifacts in WB PET/CT led to visual and quantitative distortions of the CT and attenuation-corrected PET images in the area of truncation. These artifacts can be corrected to improve the accuracy of PET/CT for diagnosis and therapy response evaluation.     

CT-based attenuation correction in the calculation of semi-quantitative indices of [<Superscript>18</Superscript>F]FDG uptake in PET

The introduction of combined PET/CT systems has a number of advantages, including the utilisation of CT images for PET attenuation correction (AC). The potential advantage compared with existing methodology is less noisy transmission maps within shorter times of acquisition. The objective of our investigation was to assess the accuracy of CT attenuation correction (CTAC) and to study resulting bias and signal to noise ratio (SNR) in image-derived semi-quantitative uptake indices. A combined PET/CT system (GE Discovery LS) was used. Different size phantoms containing variable density components were used to assess the inherent accuracy of a bilinear transformation in the conversion of CT images to 511 keV attenuation maps. This was followed by a phantom study simulating tumour imaging conditions, with a tumour to background ratio of 5:1. An additional variable was the inclusion of contrast agent at different concentration levels. A CT scan was carried out followed by 5 min emission with 1-h and 3-min transmission frames. Clinical data were acquired in 50 patients, who had a CT scan under normal breathing conditions (CTAC(nb)) or under breath-hold with inspiration (CTAC(insp)) or expiration (CTAC(exp)), followed by a PET scan of 5 and 3 min per bed position for the emission and transmission scans respectively. Phantom and patient studies were reconstructed using segmented AC (SAC) and CTAC. In addition, measured AC (MAC) was performed for the phantom study using the 1-h transmission frame. Comparing the attenuation coefficients obtained using the CT- and the rod source-based attenuation maps, differences of 3% and <6% were recorded before and after segmentation of the measured transmission maps. Differences of up to 6% and 8% were found in the average count density (SUV(avg)) between the phantom images reconstructed with MAC and those reconstructed with CTAC and SAC respectively. In the case of CTAC, the difference increased up to 27% with the presence of contrast agent. The presence of metallic implants led to underestimation in the surrounding SUV(avg) and increasing non-uniformity in the proximity of the implant. The patient study revealed no statistically significant differences in the SUV(avg) between either CTAC(nb) or CTAC(exp) and SAC-reconstructed images. The larger differences were recorded in the lung. Both the phantom and the patient studies revealed an average increase of approximately 25% in the SNR for the CTAC-reconstructed emission images compared with the SAC-reconstructed images. In conclusion, CTAC(nb) or CTAC(exp) is a viable alternative to SAC for whole-body studies. With CTAC, careful consideration should be given to interpretation of images and use of SUVs in the presence of oral contrast and in the proximity of metallic implants.     

Cause and magnitude of the error induced by oral CT contrast agent in CT-based attenuation correction of PET emission studies.

CT images represent essentially noiseless maps of photon attenuation at a range of 40-140 keV. Current dual-modality PET/CT scanners transform them into attenuation coefficients at 511 keV and use these for PET attenuation correction. The proportional scaling algorithms hereby used account for the different properties of soft tissue and bone but are not prepared to handle material with other attenuation characteristics, such as oral CT contrast agents. As a consequence, CT-based attenuation correction in the presence of an oral contrast agent results in erroneous PET standardized uptake values (SUVs). The present study assessed these errors with phantom measurements and patient data. METHODS: Two oral CT contrast agents were imaged at 3 different concentrations in dual-modality CT and PET transmission studies to investigate their attenuation properties. The SUV error due to the presence of contrast agent in CT-based attenuation correction was estimated in 10 patients with gastrointestinal tumors as follows. The PET data were attenuation corrected on the basis of the original contrast-enhanced CT images, resulting in PET images with distorted SUVs. A second reconstruction used modified CT images wherein the CT numbers representing contrast agent had been replaced by CT values producing approximately the right PET attenuation coefficients. These CT values had been derived from the data of 10 patients imaged without a CT contrast agent. The SUV error, defined as the difference between both sets of SUV images, was evaluated in regions with oral CT contrast agent, in tumor, and in reference tissue. RESULTS: The oral CT contrast agents studied increased the attenuation for 511-keV photons minimally, even at the highest concentrations found in the patients. For a CT value of 500 Hounsfield units, the proportional scaling algorithm therefore overestimated the PET attenuation coefficient by 26.2%. The resulting SUV error in the patient studies was highest in regions containing CT contrast agent (4.4% +/- 2.8%; maximum, 11.3%), whereas 1.2% +/- 1.1% (maximum, 4.1%) was found in tumors, and 0.6% +/- 0.7% was found in the reference. CONCLUSION: The use of oral contrast agents in CT has only a small effect on the SUV, and this small effect does not appear to be medically significant.     

Assessment of errors caused by X-ray scatter and use of contrast medium when using CT-based attenuation correction in PET

Purpose Quantitative image reconstruction in positron emission tomography (PET) requires an accurate attenuation map of the object under study for the purpose of attenuation correction. Current dual-modality PET/CT systems offer significant advantages over stand-alone PET, including decreased overall scanning time and increased accuracy in lesion localisation and detectability. However, the contamination of CT data with scattered radiation and misclassification of contrast medium with high-density bone in CT-based attenuation correction (CTAC) are known to generate artefacts in the attenuation map and thus the resulting PET images. The purpose of this work was to quantitatively measure the impact of scattered radiation and contrast medium on the accuracy of CTAC.Methods Our recently developed MCNP4C-based Monte Carlo X-ray CT simulator for modelling both fan- and cone-beam CT scanners and the Eidolon dedicated 3D PET Monte Carlo simulator were used to generate realigned PET/CT data sets. The impact of X-ray scattered radiation on the accuracy of CTAC was investigated through simulation of a uniform cylindrical water phantom for both a commercial fan-beam multi-slice and a prototype cone-beam flat panel detector-based CT scanner. The influence of contrast medium was studied by simulation of a cylindrical phantom containing different concentrations of contrast medium. Moreover, an experimental study using an anthropomorphic striatal phantom was conducted for quantitative evaluation of errors arising from the presence of contrast medium by calculating the apparent recovery coefficient (ARC) in the presence of different concentrations of contrast medium.Results The analysis of attenuation correction factors (ACFs) for the simulated cylindrical water phantom in both fan- and cone-beam CT scanners showed that the contamination of CT data with scattered radiation in the absence of scatter removal causes underestimation of the true ACFs, namely by 7.3% and 28.2% in the centre for the two geometries, respectively. The ARC was 190.7% for a cylindrical volume of interest located in the main chamber of the striatal phantom containing contrast medium corresponding to 2,000 Hounsfield units, whereas the ARC was overestimated by less than 5% for the main chamber and by ∼2% for the left/right putamen and caudate nucleus compared with the absence of contrast medium.Conclusion Without X-ray scatter compensation, the visual artefacts and quantitative errors in flat panel detector-based cone-beam geometry are substantial and propagate cupping artefacts to PET images during CTAC. Likewise, contrast-enhanced CT images may create considerable artefacts during CTAC in regions containing high concentrations of contrast medium.     

PET attenuation coefficients from CT images: experimental evaluation of the transformation of CT into PET 511-keV attenuation coefficients

The CT data acquired in combined PET/CT studies provide a fast and essentially noiseless source for the correction of photon attenuation in PET emission data. To this end, the CT values relating to attenuation of photons in the range of 40-140 keV must be transformed into linear attenuation coefficients at the PET energy of 511 keV. As attenuation depends on photon energy and the absorbing material, an accurate theoretical relation cannot be devised. The transformation implemented in the Discovery LS PET/CT scanner (GE Medical Systems, Milwaukee, Wis.) uses a bilinear function based on the attenuation of water and cortical bone at the CT and PET energies. The purpose of this study was to compare this transformation with experimental CT values and corresponding PET attenuation coefficients. In 14 patients, quantitative PET attenuation maps were calculated from germanium-68 transmission scans, and resolution-matched CT images were generated. A total of 114 volumes of interest were defined and the average PET attenuation coefficients and CT values measured. From the CT values the predicted PET attenuation coefficients were calculated using the bilinear transformation. When the transformation was based on the narrow-beam attenuation coefficient of water at 511 keV (0.096 cm(-1)), the predicted attenuation coefficients were higher in soft tissue than the measured values. This bias was reduced by replacing 0.096 cm(-1) in the transformation by the linear attenuation coefficient of 0.093 cm(-1) obtained from germanium-68 transmission scans. An analysis of the corrected emission activities shows that the resulting transformation is essentially equivalent to the transmission-based attenuation correction for human tissue. For non-human material, however, it may assign inaccurate attenuation coefficients which will also affect the correction in neighbouring tissue.     

The effect of metal artefact reduction on CT-based attenuation correction for PET imaging in the vicinity of metallic hip implants: a phantom study

Background

To determine if metal artefact reduction (MAR) combined with a priori knowledge of prosthesis material composition can be applied to obtain CT-based attenuation maps with sufficient accuracy for quantitative assessment of ¹⁸F-fluorodeoxyglucose uptake in lesions near metallic prostheses.

Methods

A custom hip prosthesis phantom with a lesion-sized cavity filled with 0.2 ml ¹⁸F-FDG solution having an activity of 3.367 MBq adjacent to a prosthesis bore was imaged twice with a chrome–cobalt steel hip prosthesis and a plastic replica, respectively. Scanning was performed on a clinical hybrid PET/CT system equipped with an additional external ¹³⁷Cs transmission source. PET emission images were reconstructed from both phantom configurations with CT-based attenuation correction (CTAC) and with CT-based attenuation correction using MAR (MARCTAC). To compare results with the attenuation-correction method extant prior to the advent of PET/CT, we also carried out attenuation correction with ¹³⁷Cs transmission-based attenuation correction (TXAC). CTAC and MARCTAC images were scaled to attenuation coefficients at 511 keV using a trilinear function that mapped the highest CT values to the prosthesis alloy attenuation coefficient. Accuracy and spatial distribution of the lesion activity was compared between the three reconstruction schemes.

Results

Compared to the reference activity of 3.37 MBq, the estimated activity quantified from the PET image corrected by TXAC was 3.41 MBq. The activity estimated from PET images corrected by MARCTAC was similar in accuracy at 3.32 MBq. CTAC corrected PET images resulted in nearly 40 % overestimation of lesion activity at 4.70 MBq. Comparison of PET images obtained with the plastic and metal prostheses in place showed that CTAC resulted in a marked distortion of the ¹⁸F-FDG distribution within the lesion, whereas application of MARCTAC and TXAC resulted in lesion distributions similar to those observed with the plastic replica.

Conclusions

MAR combined with a trilinear CT number mapping for PET attenuation correction resulted in estimates of lesion activity comparable in accuracy to that obtained with ¹³⁷Cs transmission-based attenuation correction, and far superior to estimates made without attenuation correction or with a standard CT attenuation map. The ability to use CT images for attenuation correction is a potentially important development because it obviates the need for a ¹³⁷Cs transmission source, which entails extra scan time, logistical complexity and expense.     

Evaluation of image registration in PET/CT of the liver and recommendations for optimized imaging.

Multimodality PET/CT of the liver can be performed with an integrated (hybrid) PET/CT scanner or with software fusion of dedicated PET and CT. Accurate anatomic correlation and good image quality of both modalities are important prerequisites, regardless of the applied method. Registration accuracy is influenced by breathing motion differences on PET and CT, which may also have impact on (attenuation correction-related) artifacts, especially in the upper abdomen. The impact of these issues was evaluated for both hybrid PET/CT and software fusion, focused on imaging of the liver. METHODS: Thirty patients underwent hybrid PET/CT, 20 with CT during expiration breath-hold (EB) and 10 with CT during free breathing (FB). Ten additional patients underwent software fusion of dedicated PET and dedicated expiration breath-hold CT (SF). The image registration accuracy was evaluated at the location of liver borders on CT and uncorrected PET images and at the location of liver lesions. Attenuation-correction artifacts were evaluated by comparison of liver borders on uncorrected and attenuation-corrected PET images. CT images were evaluated for the presence of breathing artifacts. RESULTS: In EB, 40% of patients had an absolute registration error of the diaphragm in the craniocaudal direction of >1 cm (range, -16 to 44 mm), and 45% of lesions were mispositioned >1 cm. In 50% of cases, attenuation-correction artifacts caused a deformation of the liver dome on PET of >1 cm. Poor compliance to breath-hold instructions caused CT artifacts in 55% of cases. In FB, 30% had registration errors of >1 cm (range, -4 to 16 mm) and PET artifacts were less extensive, but all CT images had breathing artifacts. As SF allows independent alignment of PET and CT, no registration errors or artifacts of >1 cm of the diaphragm occurred. CONCLUSION: Hybrid PET/CT of the liver may have significant registration errors and artifacts related to breathing motion. The extent of these issues depends on the selected breathing protocol and the speed of the CT scanner. No protocol or scanner can guarantee perfect image fusion. On the basis of these findings, recommendations were formulated with regard to scanner requirements, breathing protocols, and reporting.